Concepedia

Peter Roselt

PR

Statistics

Publications

47

Citations

2.1K

H-Index

28

Active since

1994

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Australian Nuclear Science and Technology Organisation

Monash University

Sir Charles Gairdner Hospital

Peter Roselt is an author at Peter MacCallum Cancer Centre specializing in positron emission tomography, nuclear medicine, and molecular imaging.

ORCID

Top concepts

Publications per year

1994–2023

47

Publications

47

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet Oncology · 2023 · 172 citations

, , +8

<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

Rodney J. Hicks, Price Jackson, Grace Kong et al. · Journal of Nuclear Medicine · 2018 · 140 citations · Full text

, , +19

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

Gerald Reischl, Donna S. Dorow, Carleen Cullinane et al. · PubMed · 2007 · 112 citations

A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies

Stacey E. Rudd, Peter Roselt, Carleen Cullinane et al. · Chemical Communications · 2016 · 104 citations

PET imaging of tumours with a<sup>64</sup>Cu labeled macrobicyclic cage amine ligand tethered to Tyr<sup>3</sup>-octreotate

Brett M. Paterson, Peter Roselt, Delphine Denoyer et al. · Dalton Transactions · 2013 · 98 citations

1–5 of 47